Our Team
Lars Hanan
email
301.358.2693
Lars Hanan is co-founder and Managing Partner at BroadOak. With 20 years of corporate finance and mergers and acquisitions experience, Lars Hanan has executed over 100 transactions in a broad range of industries. Prior to BroadOak, Lars built and managed the life sciences advisory business at Mercator Capital. Before joining Mercator Lars headed the M&A Group at ABN AMRO Investment Banking. In addition to heading the U.S. M&A Group, Mr. Hanan was also a member of the firm’s Fairness Opinion Committees and he was also responsible for the firm’s Healthcare M&A practice with particular sector expertise in medical technology and drug discovery tools. Prior to joining ABN AMRO, Lars held senior mergers and acquisitions positions at SG Cowen, Kidder, Peabody and Lehman Brothers where he managed a wide variety of domestic and cross border transactions. Lars currently serves on the boards of A&G Pharmaceuticals and Noxilizer.
Lars holds a B.A. in Economics from the University of Virginia and an M.B.A. from the J.L. Kellogg School of Management at Northwestern University.
Bill Snider
email
301.358.2694
Bill Snider is co-founder and Managing Partner at BroadOak. Mr. Snider has over 15 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC, a life sciences focused venture capital firm. He invested in over 20 life science companies while at ETP of which more than half were or are now publicly traded. Mr. Snider, at various times, acted as lead investor, board member and chairman for ETP’s portfolio companies. Prior to ETP he was a vice president and portfolio manager at T. Rowe Price. His responsibilities included managing $2 billion of mutual fund and institutional client portfolios. Some of Mr. Snider’s past directorships include Alpha Innotech and Atto Biosciences.
Bill holds the Chartered Financial Analysts accreditation, a B.S. in Finance and an M.B.A. from the Wharton School at the University of Pennsylvania.
D. Kyle Wilson
email
301.358.4040
Kyle Wilson is a Partner at BroadOak. With over 13 years of investment banking experience, Kyle’s background includes broad transaction experience in both capital formation and M&A. Prior to BroadOak, Kyle was a Principal at Canaccord Genuity where he led the tools and diagnostics team and completed over $1.4 billion in life sciences transactions. Kyle was also a Vice President at RBC Capital markets where he successfully executed over $700 million in transactions.
Kyle holds a B.S. in Business Administration, a Juris Doctorate and M.B.A., all from the University of Oklahoma.
Tara St. Amand, Ph.D.
email
301.358.2698
Tara St. Amand is a Vice President at BroadOak. Dr. St. Amand comes to BroadOak from Parker Boston, a private equity investment bank and advisory firm in New York City. At Parker Boston, Tara was a Director responsible for evaluating all investment banking opportunities that came to the firm and was co-lead for multiple transactions in various industries. Prior to Parker Boston, Tara worked as a Postdoctoral Fellow in the Department of Medicine at the University of California, San Diego where her research focus was cardiovascular disease. While in San Diego, Tara had the opportunity to work for a number of local biotechnology companies. She has also worked as business advisor for three biotechnology start-up companies in the New York and Philadelphia areas.
Tara received her B.S. in Biochemistry from the University of Notre Dame, her Ph.D. in Molecular Biology from Tulane University, and her M.B.A. with a concentration in Finance from Columbia University.
Matt McFarland
email
301.358.2696
Matt McFarland is an Associate at BroadOak. Prior to joining BroadOak, he worked for Morgan Stanley’s Capital Strategies Group, an investment banking division focused on middle-market mergers and acquisitions. At Morgan Stanley, Matt was responsible for a variety of sell-side activities including financial analysis, valuation, drafting memoranda and due diligence for transactions in the software, media and energy technology sectors. Prior to Morgan Stanley, Mr. McFarland led business development and sales efforts for AirOcare, Inc., a life sciences start up venture. He also was a financial analyst for Computer Sciences Corporation.
Matt holds a B.A. in Economics from Dickinson College and an M.B.A. with a concentration in Finance from the Robert H. Smith School of Business at the University of Maryland.
Kanishka Pothula
Kanishka Pothula is an Associate at BroadOak. Prior to BroadOak, he produced research for Bainbridge, Inc. in their Capital Advisory division, covering the life science and oil and gas industries. Prior to joining Bainbridge, he worked as a Research Associate at the University of California's Medical School conducting primary research on apoptotic modeling on T-lymphoma cancer cells. He was also a Research Associate in the cell biology division at Ambit Biosciences in San Diego.
Kanishka holds an M.S. in Biotechnology from Georgetown University and a B.S. in Bioengineering from the University of California, San Diego.